|
规格 |
|
| Accession Number: | NM_003775.1 |
| Cell Line: | U2OS |
| Cell State: | Dividing Cells |
| Druggable Target: | GPCRs |
| Gene Symbol: | EDG6 |
| Reporter Gene: | BLA (Beta-Lactamase) |
| System Type: | Tango™ |
| Detection Method: | Fluorescent |
|
储存 |
|
|
LiveBLAzer™-FRET B⁄G Loading Kit, Solution D and other materials are required separately; please refer to the protocol. Includes: • Tango™ EDG6-bla U2OS cells • Tango™ EDG6-bla U2OS Assay Protocol • Certificate of Analysis Storage: The Tango™ EDG6-bla U2OS cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt. |
|
描述 |
The Tango™ EDG6-bla U2OS cells contain the human Endothelial Differentiation, Lysophosphatidic Acid G-protein-coupled Receptor, 6 (EDG6) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line. This parental cell line stably expresses a beta-arrestin⁄TEV protease fusion protein and the beta-lactamase (bla) reporter gene under the control of a UAS response element.
The Tango™ EDG6-bla U2OS cells cells have been functionally validated for Z' factor and EC50 concentrations of established ligands. In addition, Tango™ EDG6-bla U2OS cells have been tested for assay performance under variable conditions. These data are found in the Validation & Assay Performance Summary for each product.
